Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION USP

Last updated on 2017-04-12 History
Report ID 2621
Drug Identification Number 02239944
Brand name KETOROLAC TROMETHAMINE INJECTION USP
Common or Proper name KETOROLAC Trometh
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETOROLAC TROMETHAMINE
Strength(s) 30MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR
Packaging size 10x1mL fiole/vial
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2015-10-30
Estimated end date 2017-04-17
Actual end date 2017-04-11
Shortage status Resolved
Updated date 2017-04-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-14 English Compare
v2 2017-03-14 French Compare
v3 2017-03-21 English Compare
v4 2017-03-21 French Compare
v5 2017-04-04 English Compare
v6 2017-04-04 French Compare
v7 2017-04-11 English Compare
v8 2017-04-11 French Compare
v9 2017-04-12 English Compare

Showing 1 to 9 of 9